Keywords: cellcor, extends, alt, study, canada, received, approval

Cellcor Extends ALT Study To Canada

Article | 19 September 1994

Print This

Cellcor has received an approval from Canada's Health Protection Branch to include Canadian patients in its pivotal Phase III study ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in